INDUSTRY ACADEMIC COOPERATION FOUNDATION; HALLYM UNIVERSITY
发明人:
CHOI, SU YOUNGKR,최수영,PARK, JIN SEOKR,박진서,UM, WON SIKKR,음원식,KIM, DUK SOOKR,김덕수,KIM, DAE WONKR,김대원
申请号：
KR1020150044854
公开号：
KR1020160117748A
申请日:
2015.03.31
申请国别(地区):
KR
年份:
2016
代理人:
摘要：
The present invention relates to a pharmaceutical composition for treating diabetes, comprising an antioxidant 1 (ATOX1) fusion protein obtained by covalently bonding a protein transportation domain on at least one of an N-terminal and a C-terminal of an ATOX1 protein. Provided is an agent for preventing and treating diabetes, having excellent effects through the activities such as the inhibition of insulin reduction or the like.COPYRIGHT KIPO 2016본 발명은 ATOX1 (Antioxidant 1) 단백질의 N-말단 및 C-말단 중 한 군데 이상에 단백질 수송 도메인이 공유결합된 ATOX1 융합단백질을 함유하는 당뇨병 치료용 약학 조성물에 관한 것이다.
